Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2013) 2 OC12 | DOI: 10.1530/boneabs.2.OC12

ICCBH2013 Oral Communications Biology (6 abstracts)

Improvement of collagen synthesis in fibroblasts of Brtl model for osteogenesis imperfecta following lentiviral-shRNA-mediated down-expression of mutant Col1a1 allele

Valérie Trichet 1, , Julie Rousseau 1, , Roberta Gioia 3 , Pierre Layrolle 1, , Dominique Heymann 1, , Antonio Rossi 3 , Joan Marini 4 & Antonella Forlino 3

13 views


1INSERM, UMR 957, Nantes, France; 2Université de Nantes, Nantes, France; 3Section of Biochemistry, Department of Molecular Medicine, University of Pavia, Pavia, Italy; 4NIH, Section of Connective Tissue Disorders, Bone and Extracellular Matrix Branch (BEMB), NICHD, Bethesda, Maryland, USA.


Objectives: The Brtl mouse, a unique model for the autosomal dominant forms of osteogenesis imperfecta was used to prove the feasibility of a lentiviral-shRNA-based strategy to improve collagen quality by targeting the mutant Col1a1 allele at the point mutation responsible for the causative substitution Gly349Cys. The ability to specifically suppress the mutant allele should convert the moderate Brtl outcome to the mild one caused by quantitative defect.

Methods: A model of human embryonic kidney cell lines which express the firefly luciferase gene combined with either wild-type or mutant Brtl Col1a1 exon 23 sequences enabled the identification of two siRNAs which were effective specifically against mutant sequence and not active against the wild-type allele\. The corresponding shRNA subcloned in a lentiviral vector were evaluated ex vivo in Brtl fibroblasts at transcript and protein levels, respectively measured by allele specific qPCR and collagen quantification after fluorescent labeling and SDS–PAGE in non reducing conditions.

Results: No effect was detected on cell proliferation, but a preferential reduction of the mutant allele transcript (up to 52%) associated to a decrease of the mutant protein (about 40%) was obtained. Interestingly a down regulation of Hsp47, a specific collagen chaperone known to be up regulated in some osteogenesis imperfecta case, was also detected. Brtl fibroblasts stably expressing the shRNA of interest and down-regulating the mutant Col1a1 were seeded in alginate to measure engraftment in mice and collagen synthesis in vivo.

Conclusion: Our data support the use of cautiously designed, lentivirus delivered-shRNAs as a strategy to specifically suppress the mutant allele making appealing the modification of mesenchymal stem cells of osteogenesis imperfecta patients for autologous transplantation.

Volume 2

6th International Conference on Children's Bone Health

Rotterdam, The Netherlands
22 Jun 2013 - 25 Jun 2013

ICCBH 

Browse other volumes

Article tools

My recent searches

No recent searches.